PharmaCom BioVet, Inc. (PHMB)
PharmaCom BioVet, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Raleigh, NC, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1.1M. Its beta of -6.74 implies it has historically moved less than the broad market.
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
PharmaCom BioVet, Inc. is most often compared with the following Healthcare names: